Continuous Glucose Monitors Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Continuous Glucose Monitors Pipeline Market Report Overview

Continuous Glucose Monitoring System is used for the continuous measurement of blood glucose. The systems include an implantable sensor with wireless transmission capability and a monitor. The Continuous Glucose Monitors pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·       The United States

·       Europe

·       Japan

·       India

·       Israel

Key Regulatory Paths ·       510(k)

·       CE

·       PMA

·       MDITAC

·       NMPA

Leading Companies ·       Advanced Biosensors-Ohio LLC

·       Advanced Medical Electronics Corp

·       Apollon Inc

·       Arkal Medical Inc (Inactive)

·       Azurite Technologies, Inc. (Inactive)

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Continuous Glucose Monitors Pipeline Market Segmentation by Territories

A few of the key territories with the Continuous Glucose Monitors pipeline market are Europe, the United States, India, Japan, and Israel among others. As of August 2024, the US had the highest number of Continuous Glucose Monitors pipeline products.

Continuous Glucose Monitors Pipeline Market Analysis by Territories, 2024 (%)

Continuous Glucose Monitors Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Continuous Glucose Monitors Pipeline Market

Download a Free Report Sample

Continuous Glucose Monitors Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths in the Continuous Glucose Monitors pipeline products market are 510(k), CE, PMA, MDITAC, and NMPA. As of August 2024, 510(k) was the most followed pathway for pipeline products in the Continuous Glucose Monitors market.

Continuous Glucose Monitors Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Continuous Glucose Monitors Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Continuous Glucose Monitors Pipeline Market

Download a Free Report Sample

Continuous Glucose Monitors Pipeline Market – Competitive Landscape

A few of the key companies associated with the Continuous Glucose Monitors pipeline market are Advanced Biosensors-Ohio LLC, Advanced Medical Electronics Corp, Apollon Inc., Arkal Medical Inc. (Inactive), and Azurite Technologies, Inc. (Inactive) among others.

Advanced Medical Electronics Corp (AME): AME is a medical device company that provides research and development services. The company’s products include original equipment manufacturer (OEM) devices, battery-powered surgical headlamps, wrist-worn pulse oximeters, amplitude-integrated, electroencephalographs, partial polysomnographs, computerized visual acuity testing, among others. Original equipment manufacturer (OEM) devices include electrocardiograph and spirometer. It offers systems design, embedded design, electronics and instrumentation design, wireless design, software development, system testing, and prototype building, among others. AME is headquartered in Maple Grove, Minnesota, the US.

Continuous Glucose Monitors Pipeline Market Analysis by Companies, 2024
Continuous Glucose Monitors Pipeline Market Analysis by Companies, 2024Buy the Full Report for More Company Insights into the Continuous Glucose Monitors Pipeline Market
Download a Free Report Sample

Segments Covered in the Report

Continuous Glucose Monitors Pipeline Market Territories Outlook (2024)

  • Europe
  • The US
  • India
  • Japan
  • Israel

Continuous Glucose Monitors Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • PMA
  • MDITAC
  • NMPA

Scope

This report provides:

  • Extensive coverage of the Continuous Glucose Monitors devices under development.
  • Exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Continuous Glucose Monitors and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Continuous Glucose Monitors under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Advanced Biosensors-Ohio LLC
Advanced Medical Electronics Corp
Apollon Inc
Arkal Medical Inc (Inactive)
Azurite Technologies, Inc. (Inactive)
Biovotion AG
CALISTO MEDICAL, INC. (Inactive)
CGM3 Ltd
City, University of London
Columbia University
ConvaTec Group Plc
Cyber Medical Ltd (Inactive)
DexCom Inc
Echo Therapeutics Inc (Inactive)
Eclypia
eLutions Integrated Systems, Inc.
Flowsion A/S
Gili Medical Ltd
Globe Medical Tech Inc (Inactive)
GlucoLight Corporation (Inactive)
Glucometrix AG
GlucoModicum Oy
Glucosense Diagnostics Ltd (Inactive)
GlucoTrack Inc
Glucovation Inc
GluMetrics Inc
Glusense Ltd
GlySens Inc
Guided Therapeutics Inc
Hagar Tech
iGlyko, Inc. (Inactive)
Innovosens AB
Invivosense ASA (Inactive)
I-Sens Inc
KTH Royal Institute of Technology
LEMM Technologies, LLC
Medtronic MiniMed Inc
Metronom Health Inc
MicroTech Medical Inc
mobiLIFE
Nemaura Medical Inc
Newton Photonics Inc
Northwestern University
PKvitality SAS
Purdue University
SD Biosensor Inc
Senseonics Holdings Inc
SensiVida Medical Technologies, Inc. (Inactive)
Socrates Health Solutions, Inc.
Stony Brook University
Swansea University
Tandem Diabetes Care Inc
Tenax Therapeutics Inc
Texas A&M University
Ultradian Diagnostics LLC
University of California Berkeley
University of California Irvine
University of California San Diego
University of South Carolina
University of South Florida
University of Technology Sydney
University of Texas at Arlington
Uxn Co Ltd
VeriTeQ Corporation

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 12

2 Introduction 13

2.1 Continuous Glucose Monitors Overview 13

3 Products under Development 14

3.1 Continuous Glucose Monitors – Pipeline Products by Stage of Development 14

3.2 Continuous Glucose Monitors – Pipeline Products by Territory 15

3.3 Continuous Glucose Monitors – Pipeline Products by Regulatory Path 16

3.4 Continuous Glucose Monitors – Pipeline Products by Estimated Approval Date 17

3.5 Continuous Glucose Monitors – Ongoing Clinical Trials 18

4 Continuous Glucose Monitors – Pipeline Products under Development by Companies 19

4.1 Continuous Glucose Monitors Companies – Pipeline Products by Stage of Development 19

4.2 Continuous Glucose Monitors – Pipeline Products by Stage of Development 22

5 Continuous Glucose Monitors Companies and Product Overview 24

5.1 Advanced Biosensors-Ohio LLC Company Overview 24

5.1.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 24

5.2 Advanced Medical Electronics Corp Company Overview 25

5.2.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 25

5.3 Apollon Inc Company Overview 26

5.3.1 Apollon Inc Pipeline Products & Ongoing Clinical Trials Overview 26

5.4 Arkal Medical Inc (Inactive) Company Overview 27

5.4.1 Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27

5.5 Azurite Technologies, Inc. (Inactive) Company Overview 28

5.5.1 Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

5.6 Biovotion AG Company Overview 29

5.6.1 Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 29

5.7 CALISTO MEDICAL, INC. (Inactive) Company Overview 30

5.7.1 CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

5.8 CGM3 Ltd Company Overview 31

5.8.1 CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

5.9 City, University of London Company Overview 32

5.9.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 32

5.10 Columbia University Company Overview 33

5.10.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 33

5.11 ConvaTec Group Plc Company Overview 34

5.11.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 34

5.12 Cyber Medical Ltd (Inactive) Company Overview 35

5.12.1 Cyber Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35

5.13 DexCom Inc Company Overview 36

5.13.1 DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 36

5.14 Echo Therapeutics Inc (Inactive) Company Overview 38

5.14.1 Echo Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38

5.15 Eclypia Company Overview 41

5.15.1 Eclypia Pipeline Products & Ongoing Clinical Trials Overview 41

5.16 eLutions Integrated Systems, Inc. Company Overview 42

5.16.1 eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42

5.17 Flowsion A/S Company Overview 43

5.17.1 Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview 43

5.18 Gili Medical Ltd Company Overview 44

5.18.1 Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

5.19 Globe Medical Tech Inc (Inactive) Company Overview 45

5.19.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 45

5.20 GlucoLight Corporation (Inactive) Company Overview 46

5.20.1 GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

5.21 Glucometrix AG Company Overview 47

5.21.1 Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview 47

5.22 GlucoModicum Oy Company Overview 48

5.22.1 GlucoModicum Oy Pipeline Products & Ongoing Clinical Trials Overview 48

5.23 Glucosense Diagnostics Ltd (Inactive) Company Overview 49

5.23.1 Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49

5.24 GlucoTrack Inc Company Overview 50

5.24.1 GlucoTrack Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.25 Glucovation Inc Company Overview 51

5.25.1 Glucovation Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.26 GluMetrics Inc Company Overview 52

5.26.1 GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.27 Glusense Ltd Company Overview 53

5.27.1 Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

5.28 GlySens Inc Company Overview 54

5.28.1 GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.29 Guided Therapeutics Inc Company Overview 58

5.29.1 Guided Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 58

5.30 Hagar Tech Company Overview 59

5.30.1 Hagar Tech Pipeline Products & Ongoing Clinical Trials Overview 59

5.31 iGlyko, Inc. (Inactive) Company Overview 61

5.31.1 iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 61

5.32 Innovosens AB Company Overview 62

5.32.1 Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview 62

5.33 Invivosense ASA (Inactive) Company Overview 63

5.33.1 Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 63

5.34 I-Sens Inc Company Overview 64

5.34.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.35 KTH Royal Institute of Technology Company Overview 66

5.35.1 KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 66

5.36 LEMM Technologies, LLC Company Overview 67

5.36.1 LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 67

5.37 Medtronic MiniMed Inc Company Overview 68

5.37.1 Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.38 Metronom Health Inc Company Overview 69

5.38.1 Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.39 MicroTech Medical Inc Company Overview 70

5.39.1 MicroTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.40 mobiLIFE Company Overview 71

5.40.1 mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview 71

5.41 Nemaura Medical Inc Company Overview 72

5.41.1 Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 72

5.42 Newton Photonics Inc Company Overview 76

5.42.1 Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.43 Northwestern University Company Overview 77

5.43.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 77

5.44 PKvitality SAS Company Overview 78

5.44.1 PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview 78

5.45 Purdue University Company Overview 81

5.45.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 81

5.46 SD Biosensor Inc Company Overview 82

5.46.1 SD Biosensor Inc Pipeline Products & Ongoing Clinical Trials Overview 82

5.47 Senseonics Holdings Inc Company Overview 84

5.47.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 84

5.48 SensiVida Medical Technologies, Inc. (Inactive) Company Overview 85

5.48.1 SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 85

5.49 Socrates Health Solutions, Inc. Company Overview 86

5.49.1 Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86

5.50 Stony Brook University Company Overview 87

5.50.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 87

5.51 Swansea University Company Overview 88

5.51.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview 88

5.52 Tandem Diabetes Care Inc Company Overview 90

5.52.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.53 Tenax Therapeutics Inc Company Overview 91

5.53.1 Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 91

5.54 Texas A&M University Company Overview 92

5.54.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 92

5.55 Ultradian Diagnostics LLC Company Overview 93

5.55.1 Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 93

5.56 University of California Berkeley Company Overview 94

5.56.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 94

5.57 University of California Irvine Company Overview 95

5.57.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 95

5.58 University of California San Diego Company Overview 96

5.58.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 96

5.59 University of South Carolina Company Overview 97

5.59.1 University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 97

5.60 University of South Florida Company Overview 98

5.60.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 98

5.61 University of Technology Sydney Company Overview 99

5.61.1 University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview 99

5.62 University of Texas at Arlington Company Overview 100

5.62.1 University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview 100

5.63 Uxn Co Ltd Company Overview 101

5.63.1 Uxn Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

5.64 VeriTeQ Corporation Company Overview 104

5.64.1 VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview 104

6 Continuous Glucose Monitors- Recent Developments 105

6.1 Aug 08, 2024: Quebec Expands Public Reimbursement of Abbott’s FreeStyle Libre 2 Flash Glucose Monitoring System to More Adults with Diabetes 105

6.2 Aug 07, 2024: Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic’s Insulin Delivery Devices 105

6.3 Jul 31, 2024: Abbott Issues Voluntary Medical Device Correction for a Small Number of FreeStyle Libre 3 Sensors in the U.S. 106

6.4 Jul 24, 2024: Abbott Issues Voluntary Medical Device Correction for a Small Number of Freestyle Libre 3 Sensors in the U.S 107

6.5 Jul 08, 2024: Henry Schein to Webcast Second Quarter 2024 Conference Call on Tuesday, August 6, 2024 at 10:00 a.m. ET 108

6.6 Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings 108

6.7 Jun 24, 2024: Trinity Biotech to Begin European Pre-pivotal Trial to Optimize Its CGM Sensor 108

6.8 Jun 20, 2024: Dexcom Expands AID Partnership Into The Netherlands 108

6.9 Jun 19, 2024: Abbott Diabetes Receives 510(K) Clearance For Libre Rio Continuous Glucose Monitoring System 109

6.10 Jun 19, 2024: Hagar Announces Published Clinical Data on GWave Technology 109

6.11 Jun 17, 2024: GlucoModicum ups manufacturing after positive data for needle-free CGM 110

6.12 Jun 13, 2024: Abbott Medical Receives 510(K) Clearance For Lingo Glucose 111

6.13 Jun 13, 2024: Medtronic Confirms Global Layoffs 111

6.14 Jun 11, 2024: FDA approves Abbott’s Lingo and Libre Rio glucose monitoring systems 111

6.15 Jun 03, 2024: Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems 112

6.16 May 21, 2024: Henry Schein to Present at Investor Conferences in June 2024 113

6.17 May 17, 2024: Senseonics Receives DeNovo Clearance for Eversense AP CGM System 113

6.18 May 13, 2024: Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management 113

6.19 May 06, 2024: Abbott Diabetes Care Receives An Additional 510(k) Clearance For FreeStyle Libre 2 Flash Glucose Monitoring System 114

6.20 May 06, 2024: Abbott Diabetes Care Receives An Additional 510(k) Clearance For FreeStyle Libre 3 Continuous Glucose Monitoring System 115

6.21 Apr 30, 2024: Glutality powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology 115

6.22 Apr 19, 2024: Lee’s Pharmaceutical Notice of Annual General Meeting 115

6.23 Apr 08, 2024: Draper Drives Growth Strategy with Appointment of Carrie George as Chief Financial Officer 116

6.24 Apr 03, 2024: Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024 116

6.25 Mar 26, 2024: Going Beyond Blood Glucose Monitoring: How CGM’s Panoramic Perspective Redefines Diabetes Management 116

6.26 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 116

6.27 Mar 06, 2024: Know Labs’ Non-Invasive Glucose Monitor Achieves

11.1% MARD in Latest Clinical Research Study 117

6.28 Mar 06, 2024: Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029 118

6.29 Mar 04, 2024: Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes 120

6.30 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference 122

6.31 Feb 13, 2024: Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference 122

6.32 Feb 09, 2024: Invitation to Senzime’s Fourth Quarter 2023 Report Presentation 122

6.33 Feb 06, 2024: Dexcom launches real-time CGM solution Dexcom ONE+ in Europe 122

6.34 Jan 17, 2024: Huons Donates 6,000 Continuous Glucose Monitors To Type 1 Diabetes Patients 123

6.35 Jan 11, 2024: Veri Releases New Metabolic Health Program 124

6.36 Jan 03, 2024: Henry Schein to Present at J.P. Morgan’s Healthcare Investor Conference 124

6.37 Nov 12, 2023: Mubadala Health Kicks Off Two-Day Diabetes Conference in Abu Dhabi 124

6.38 Nov 07, 2023: Henry Schein to Present at Upcoming Investor Conferences in November 2023 125

6.39 Oct 23, 2023: Invitation to Senzime’s Third Quarter 2023 Report Presentation 126

6.40 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023 126

6.41 Oct 10, 2023: Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023 126

6.42 Sep 19, 2023: Abbott and Weightwatchers Connected App Experience Is Now Available for People Living With Diabetes 126

6.43 Sep 19, 2023: Lifecare – Sanofi Product Development Agreement Update 127

6.44 Sep 11, 2023: Nemaura Medical Completes 100 Patient Study for Sugarbeat 24-Hour Wear and Reports Interim Results 128

6.45 Sep 05, 2023: Henry Schein to Present at Investor Conferences in September 2023 128

6.46 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference 128

7 Appendix 129

7.1 Methodology 129

7.2 About GlobalData 132

7.3 Contact Us 132

7.4 Disclaimer 132

Table

Continuous Glucose Monitors – Pipeline Products by Stage of Development 14

Continuous Glucose Monitors – Pipeline Products by Territory 15

Continuous Glucose Monitors – Pipeline Products by Regulatory Path 16

Continuous Glucose Monitors – Pipeline Products by Estimated Approval Date 17

Continuous Glucose Monitors – Ongoing Clinical Trials 18

Continuous Glucose Monitors Companies – Pipeline Products by Stage of Development 19

Continuous Glucose Monitors – Pipeline Products by Stage of Development 22

Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 24

My Medibit – Product Status 24

My Medibit – Product Description 24

Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 25

Continuous Glucose Monitor – Product Status 25

Continuous Glucose Monitor – Product Description 25

Apollon Inc Pipeline Products & Ongoing Clinical Trials Overview 26

Raman Spectroscopy – Non-Invasive Continuous Glucose Monitor – Product Status 26

Raman Spectroscopy – Non-Invasive Continuous Glucose Monitor – Product Description 26

Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 27

GlucoPod CGM System – Product Status 27

GlucoPod CGM System – Product Description 27

Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 28

Blood Glucose Sensor – Product Status 28

Blood Glucose Sensor – Product Description 28

Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 29

VSM 3 Glucose Monitoring System – Product Status 29

VSM 3 Glucose Monitoring System – Product Description 29

CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

Glucoband – Product Status 30

Glucoband – Product Description 30

CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 31

Miniaturized Implantable Continuous Glucose Monitor – Product Status 31

Miniaturized Implantable Continuous Glucose Monitor – Product Description 31

City, University of London Pipeline Products & Ongoing Clinical Trials Overview 32

Non-Invasive Glucose Monitor – Product Status 32

Non-Invasive Glucose Monitor – Product Description 32

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 33

Wearable Continuous Blood Glucose Monitoring Device – Product Status 33

Wearable Continuous Blood Glucose Monitoring Device – Product Description 33

ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 34

Closed Loop Continuous Glucose Monitoring System – Product Status 34

Closed Loop Continuous Glucose Monitoring System – Product Description 34

Cyber Medical Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35

Cybersensors Continuous Glucose Sensor – Product Status 35

Cybersensors Continuous Glucose Sensor – Product Description 35

DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 36

DexCom CGM With Accu-Chek Insulin Delivery System – Product Status 36

DexCom CGM With Accu-Chek Insulin Delivery System – Product Description 37

First-Gen Verily Sensor – Product Status 37

First-Gen Verily Sensor – Product Description 37

Echo Therapeutics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 38

Display – Continuous Glucose Monitoring – Product Status 38

Display – Continuous Glucose Monitoring – Product Description 38

Gen 2 Symphony CGM System – Product Status 39

Gen 2 Symphony CGM System – Product Description 39

Symphony tCGM System – Home – Product Status 39

Symphony tCGM System – Home – Product Description 40

Symphony tCGM System – Hospital Critical Care – Product Status 40

Symphony tCGM System – Hospital Critical Care – Product Description 40

Eclypia Pipeline Products & Ongoing Clinical Trials Overview 41

Non Invasive Continuous Glucose Monitoring Device – Product Status 41

Non Invasive Continuous Glucose Monitoring Device – Product Description 41

eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42

Optically-Efficient Miniaturized Raman Optical System – Product Status 42

Optically-Efficient Miniaturized Raman Optical System – Product Description 42

Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview 43

Glycostat – Product Status 43

Glycostat – Product Description 43

Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

Diawatch – Product Status 44

Diawatch – Product Description 44

Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 45

Continuous Glucose Monitoring Device – Product Status 45

Continuous Glucose Monitoring Device – Product Description 45

GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 46

SENTRIS-100 – Product Status 46

SENTRIS-100 – Product Description 46

Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview 47

Non-Invasive Blood Glucose Monitoring Device – Product Status 47

Non-Invasive Blood Glucose Monitoring Device – Product Description 47

GlucoModicum Oy Pipeline Products & Ongoing Clinical Trials Overview 48

Talisman – Product Status 48

Talisman – Product Description 48

Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49

Non-Invasive Blood Glucose Monitor – Product Status 49

Non-Invasive Blood Glucose Monitor – Product Description 49

GlucoTrack Inc Pipeline Products & Ongoing Clinical Trials Overview 50

GlucoTrack – DF-C – Product Status 50

GlucoTrack – DF-C – Product Description 50

Glucovation Inc Pipeline Products & Ongoing Clinical Trials Overview 51

GW Wearable Glucose Sensor – Product Status 51

GW Wearable Glucose Sensor – Product Description 51

GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 52

GluCath Intravascular Continuous Glucose Monitor – Product Status 52

GluCath Intravascular Continuous Glucose Monitor – Product Description 52

Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview 53

Glyde CGM – Product Status 53

Glyde CGM – Product Description 53

GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Eclipse 3 ICGM System – Product Status 54

Eclipse 3 ICGM System – Product Description 54

Eclipse ICGM System – Product Status 55

Eclipse ICGM System – Product Description 55

GlySens Inc – Ongoing Clinical Trials Overview 56

Eclipse 3 ICGM System – Feasibility Trial to Evaluate the Eclipse 3 Continuous Glucose Monitoring System for Individuals with Type 1 Diabetes Mellitus – Australia (FREE – AU Trial) 57

Guided Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 58

Altea MicroPor Laser – Product Status 58

Altea MicroPor Laser – Product Description 58

Hagar Tech Pipeline Products & Ongoing Clinical Trials Overview 59

GWave – Product Status 59

GWave – Product Description 59

GWave 2.0 – Product Status 60

GWave 2.0 – Product Description 60

iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 61

iGlyko System – Product Status 61

iGlyko System – Product Description 61

Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview 62

Diabetic Sensor – Continuous Glucose Monitoring – Product Status 62

Diabetic Sensor – Continuous Glucose Monitoring – Product Description 62

Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 63

IvSCGM Biosensor – Product Status 63

IvSCGM Biosensor – Product Description 63

I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 64

CareSens Air Glucose Monitoring System – Product Status 64

CareSens Air Glucose Monitoring System – Product Description 64

Continuous Blood Glucose Meter – Product Status 65

Continuous Blood Glucose Meter – Product Description 65

KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 66

Microneedle Patch – Glucose Monitoring – Product Status 66

Microneedle Patch – Glucose Monitoring – Product Description 66

LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 67

Non-Invasive Blood Glucose Monitor – Product Status 67

Non-Invasive Blood Glucose Monitor – Product Description 67

Medtronic MiniMed Inc Pipeline Products & Ongoing Clinical Trials Overview 68

iPro 3 Glucose Monitoring System – Product Status 68

iPro 3 Glucose Monitoring System – Product Description 68

Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview 69

CGM System – Product Status 69

CGM System – Product Description 69

MicroTech Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 70

AiDex X – Product Status 70

AiDex X – Product Description 70

mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview 71

GlucoReader – Product Status 71

GlucoReader – Product Description 71

Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 72

sugarBEAT – Product Status 72

sugarBEAT – Product Description 73

Nemaura Medical Inc – Ongoing Clinical Trials Overview 74

sugarBEAT – Study is to Compare the sugarBEAT and Major Continuous Glucose Monitor Sensor in People with Diabetes 75

Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 76

Non-invasive Blood Glucose Monitor – Product Status 76

Non-invasive Blood Glucose Monitor – Product Description 76

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 77

Continuous Glucose Sensor – Product Status 77

Continuous Glucose Sensor – Product Description 77

PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview 78

K’Watch Glucose – Product Status 78

K’Watch Glucose – Product Description 78

PKvitality SAS – Ongoing Clinical Trials Overview 79

K’Watch Glucose – Clinical Investigation of K’Watch – Lab & Home Study 80

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 81

Soft Contact Lens – Product Status 81

Soft Contact Lens – Product Description 81

SD Biosensor Inc Pipeline Products & Ongoing Clinical Trials Overview 82

All-In-One Next-Generation Continuous Glucose Monitoring System – Product Status 82

All-In-One Next-Generation Continuous Glucose Monitoring System – Product Description 82

Continuous Glucose Monitoring System – Product Status 83

Continuous Glucose Monitoring System – Product Description 83

Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 84

Eversense CGM+RPM System – Product Status 84

Eversense CGM+RPM System – Product Description 84

SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 85

Glucose Monitoring System – Product Status 85

Glucose Monitoring System – Product Description 85

Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86

Companion CM – Product Status 86

Companion CM – Product Description 86

Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 87

GlucoREAD Patch – Product Status 87

GlucoREAD Patch – Product Description 87

Swansea University Pipeline Products & Ongoing Clinical Trials Overview 88

Flash Glucose Monitoring Device – Product Status 88

Flash Glucose Monitoring Device – Product Description 88

Hi-Tech Diabetes Blood Glucose Monitor – Product Status 89

Hi-Tech Diabetes Blood Glucose Monitor – Product Description 89

Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 90

Next Generation Closed Loop – Product Status 90

Next Generation Closed Loop – Product Description 90

Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 91

Glucose Biosensor – Product Status 91

Glucose Biosensor – Product Description 91

Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 92

Minimally Invasive Glucose Monitoring System – Product Status 92

Minimally Invasive Glucose Monitoring System – Product Description 92

Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 93

Biologue – Product Status 93

Biologue – Product Description 93

University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 94

Dropsense Continuous Glucose Monitor – Product Status 94

Dropsense Continuous Glucose Monitor – Product Description 94

University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 95

Implantable Device – Diabetes Mellitus – Product Status 95

Implantable Device – Diabetes Mellitus – Product Description 95

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 96

Glucose Monitoring Tattoo – Product Status 96

Glucose Monitoring Tattoo – Product Description 96

University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 97

Continuous Glucose Monitoring System – Product Status 97

Continuous Glucose Monitoring System – Product Description 97

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 98

Long Term Silicon Carbide (SiC) RF Antenna – Product Status 98

Long Term Silicon Carbide (SiC) RF Antenna – Product Description 98

University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview 99

Hypo Detection System – Product Status 99

Hypo Detection System – Product Description 99

University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview 100

Nanotechnology Based Glucose Monitoring Device – Product Status 100

Nanotechnology Based Glucose Monitoring Device – Product Description 100

Uxn Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

Always Glucose Monitoring System (AGMS) – Product Status 101

Always Glucose Monitoring System (AGMS) – Product Description 101

Continuous Blood Glucose Meter – Product Status 102

Continuous Blood Glucose Meter – Product Description 102

Implantable Continuous Blood Glucose Meter – Product Status 102

Implantable Continuous Blood Glucose Meter – Product Description 103

Microneedle Continuous Blood Glucose Meter – Product Status 103

Microneedle Continuous Blood Glucose Meter – Product Description 103

VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview 104

GlucoChip – Product Status 104

GlucoChip – Product Description 104

Glossary 131

Figures

Continuous Glucose Monitors – Pipeline Products by Stage of Development 14

Continuous Glucose Monitors – Pipeline Products by Territory 15

Continuous Glucose Monitors – Pipeline Products by Regulatory Path 16

Continuous Glucose Monitors – Pipeline Products by Estimated Approval Date 17

Continuous Glucose Monitors – Ongoing Clinical Trials 18

Frequently asked questions

Continuous Glucose Monitors Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Continuous Glucose Monitors Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Continuous Glucose Monitors Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Continuous Glucose Monitors Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.